Back to search results

Inflammation, Diabetes, Ethnicity and Obesity (IDEO) Cohort Study

This is an observational study called the Inflammation, Diabetes, Ethnicity and Obesity (IDEO) Cohort. Researchers are looking to understand more about obesity, diabetes, and pre-diabetes by collecting data and samples from 350 healthy individuals. You may be able to join if you are between 18 and 75 years old, with or without type 2 diabetes or metabolic syndrome, and have a stable weight. The study also includes people planning to have bariatric (weight loss) surgery or other abdominal surgery at UCSF. The main goal is to gather enough participants over seven years to encourage new research ideas about obesity.

Study design
This is an observational study aiming to recruit 350 participants. It is not testing a specific intervention or drug.
What's involved
Participants will provide data and blood, stool, and adipose tissue (fat) samples. The record does not specify the number of visits or the duration of participation.
Compensation
Not stated in the trial record.
Follow-up
The primary goal is to complete recruitment over seven years, but the duration of individual participant follow-up is not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT03022682

Inflammation, Diabetes, Ethnicity and Obesity Cohort

Recruiting
Not specifiedAges 18–75Observational
University of California, San Francisco
~350 participants
Updated 2025-07-04 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Complete recruitment of IDEO cohort participants to spur novel and creative interactions between investigators that have transformative potential in obesity research.
Measured over 7 years

Conditions

Obesity
Diabetes Mellitus
Pre Diabetes

Explore related trials

Diabetes MellitusMetabolic SyndromeObesity

Where it's being run

1 sites across 1 states
California1

Study leadership

  • Suneil Koliwad, MD,PhD · PRINCIPAL_INVESTIGATOR · University of California, San Francisco

Who to contact

Suneil Koliwad, MD,PhD
[email protected]
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Participants will be healthy individuals between the ages of 18-75 years. These cutoffs are designed to allow inclusion of postmenopausal women, and younger/more active patients who are increasingly undergoing bariatric surgery.
Patients with either diabetes type 2 or the metabolic syndrome will be included in the cohort.

Exclusion

Participants with chronic kidney disease (\> stage 4)
Autoimmune/inflammatory disease (e.g., Lupus, Ulcerative Colitis, etc.)
Unstable angina, New York (NY) class III or IV congestive heart failure or myocardial infarction within 3 months of entry
Clinically significant liver disease (e.g. Cirrhosis or liver failure)
Weight \> 450 pounds (DXA scan weight limit)
History of organ transplant
Treatment with chemotherapy or radiation therapy at the time of enrollment in study.
Poorly controlled asthma (participants requiring inhaled glucocorticoids and/or oral glucocorticoids)
Current nasal corticosteroid use (within the past month)
Excessive alcohol or substance abuse
Current use of anabolic steroids or testosterone for bodybuilding purposes. Testosterone use is permitted if prescribed for hypogonadism and dose stable for the past 6 months.
Patients actively enrolled in interventional trials involving investigational agents
Pregnant or breast-feeding women
Appears unlikely or unable to participate in the required study procedures as assessed by the investigator, study coordinator or designee.
History of abnormal clotting
Previous bariatric surgery
Anticoagulant use
Methadone medication

What this trial measures

  • Complete recruitment of IDEO cohort participants to spur novel and creative interactions between investigators that have transformative potential in obesity research.7 years

    Number of biological samples collected